Patent Yard Sign in
Canadian application, no grantCanada

Method of diagnosis of inflammatory diseases using calgranulin c

CA 2474890 A1 · Owner: Sorg, Clemens · Inventors: Sorg, Clemens; Roth, Johannes

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

The present invention is directed to a method for diagnosing inflammatory diseases based on the marker CALGRANULIN C particularly for diagnosing , specific stages of inflammatory diseases and/or for determining the risk of relapse and/or for discriminating between diseases with similar symptoms said , method comprising the steps of (a) obtaining a biological sample of mammalian body fluid or tissue to be diagnosed; (b) determining the amount and/or con~centration of CALGRANULIN C polypeptide and/or nucleic acids encoding the polypeptide present in said biological sample; and (c) comparing the amount and/or concentration of CALGRANULIN C polypeptide determine in said biological sample …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed February 17, 2003. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 17, 2023.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 17, 2025.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledFebruary 17, 2003
GrantedNo grant recorded
Term endedFebruary 17, 2023
Patent numberCA 2474890 A1
Classification (IPC)G01N33/56 +1 more

Timeline

Timeline From CIPO dates

2004200620082010201220142016201820202022Application filedFeb 17, 2003Term endedFeb 17, 2023

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.